Resveratrol reverses Doxorubicin resistance by inhibiting epithelial-mesenchymal transition (EMT) through modulating PTEN/Akt signaling pathway in gastric cancer

Jiahui Xu(Nanfang Hospital), Qingling Zhang(Jilin University)
Journal of Experimental & Clinical Cancer Research
January 26, 2017
Cited by 273


Related Papers